A narrative review of targeted therapy in meningioma, pituitary adenoma, and craniopharyngioma of the skull base.

NL Martinez, O Khanna, CJ Farrell - 2020 - jdc.jefferson.edu
Management of solid tumors involving the skull base are primarily managed with surgery
and radiation, though proximity to important vascular and neuroanatomic structures often …

Case-Based Review: meningioma

SE Fogh, DR Johnson, FG Barker… - Neuro-oncology …, 2016 - academic.oup.com
Meningioma is by far the most common primary intracranial tumor in adults. Treatment of
meningioma is complex due to a tremendous amount of variability in tumor behavior. Many …

Therapeutics for childhood neurofibromatosis type 1 and type 2

SL Ardern-Holmes, KN North - Current treatment options in neurology, 2011 - Springer
Opinion statement Neurofibromatosis type 1 (NF1) and type 2 (NF2) are genetically and
medically distinct neurocutaneous disorders that are both associated with tumors affecting …

Anaplastic meningioma: octreotide therapy for a case of recurrent and progressive intracranial disease

R Rammo, A Rock, A Transou, A Raghunathan… - Journal of …, 2016 - thejns.org
Meningiomas are common intracranial tumors categorized as Grades I–III per the current
WHO guidelines. A small percentage of meningiomas are Grades II and III, which are likely …

Case report and literature review: exploration of molecular therapeutic targets in recurrent malignant meningioma through comprehensive genetic analysis with Todai …

K Ohara, S Miyawaki, H Nakatomi, A Okano… - Frontiers in …, 2023 - frontiersin.org
Background Despite accumulating research on the molecular characteristics of
meningiomas, no definitive molecularly targeted therapy for these tumors has been …

DNA Microarray Analysis Identifies CKS2 and LEPR as Potential Markers of Meningioma Recurrence

F Menghi, FN Orzan, M Eoli, M Farinotti… - The …, 2011 - academic.oup.com
Meningiomas are the most frequent intracranial tumors. Surgery can be curative, but
recurrences are possible. We performed gene expression analyses and loss of …

Management of Atypical and Anaplastic Meningiomas

D Higgins, AH Shah, RJ Komotar… - Neurosurgery …, 2023 - neurosurgery.theclinics.com
Although meningiomas are generally thought of as benign lesions, a small proportion
displays more aggressive behavior. Although difficult to assess their incidence, recent data …

Imatinib mesylate plus hydroxyurea chemotherapy for cerebellar meningioma in a Belgian Malinois dog

HW Jung, HC Lee, JH Kim, HM Jang… - Journal of Veterinary …, 2014 - jstage.jst.go.jp
An 8-year-old intact male Belgian Malinois, weighing 37.2 kg, was referred for evaluation
due to right side facial paresis, ataxia and a 2-month history of decreased cognitive ability …

Metronidazole leads to enhanced uptake of imatinib in brain, liver and kidney without affecting its plasma pharmacokinetics in mice

SY Tan, E Kan, WY Lim, G Chay… - Journal of Pharmacy …, 2011 - academic.oup.com
Objectives The pharmacokinetic interaction between metronidazole, an antibiotic–
antiparasitic drug used to treat anaerobic bacterial and protozoal infections, and imatinib, a …

A five year-old child with clear cell petro-clival meningioma: case report with clinical and histopathological long-term follow-up

TA Juratli, KD Geiger, P Weigel, M von der Hagen… - Child's Nervous …, 2015 - Springer
Background Only a few cases have been previously published about clear cell
meningiomas in children, the majority of them in the location of the spine. We describe an …